Key result
RF ablation reverses tachycardia-induced cardiomyopathy in an infant with SVT, allowing 8-month medication-free recovery.
Why the study?
Tachycardia-induced cardiomyopathy in infants with incessant supraventricular tachycardia refractory to medical treatment requires evaluation of reversibility after radiofrequency ablation.
Does transcatheter radiofrequency ablation improve symptoms in infants with tachycardia-induced cardiomyopathy due to medically refractory permanent junctional reciprocating tachycardia?
Does transcatheter radiofrequency ablation improve symptoms in infants with tachycardia-induced cardiomyopathy due to medically refractory permanent junctional reciprocating tachycardia?
Transcatheter radiofrequency ablation can successfully and safely treat tachycardia-induced cardiomyopathy in infants with medically refractory permanent junctional reciprocating tachycardia.
Answers are grounded in this paper and cite their sources.
Supports ablation feasibility in refractory infant PJRT cardiomyopathy; leaves open need for larger pediatric studies.
Tachycardia-induced cardiomyopathy developed in a 3 month old infant with permanent junctional reciprocating tachycardia, which was incessant despite medical treatment. The patient underwent transcatheter radiofrequency ablation. There were no complications and 8 months after the procedure the patient was symptom free without medication.
No takes yet. Share an insight, caveat, or question.
Benito et al. (1995) studied this question. Radiofrequency ablation reversed tachycardia-induced cardiomyopathy in an infant with incessant supraventricular tachycardia, leaving the patient symptom-free without medication at 8 months.
Synapse has enriched 10 related papers. Consider them for comparative context: